Current treatments of Type 2 diabetes can help the body use insulin at various stages of the disease, but they can also be expensive and subject patients to lifelong medication regimens and side effects. Thanks to new therapeutic ultrasound technology, one promising alternative looks to reshape how early Type 2 diabetes is managed. A group of researchers has used ultrasound therapy to stimulate insulin release from mice on demand. The team will present their findings at the 177th ASA Meeting, May 13-17. This image shows the experimental setup. A flat, unfocused ultrasound transducer was positioned transcutaneously over the abdomen and positioning was confirmed through ultrasound imaging. Heart rate and body temperature were monitored throughout.